Ma, Chunying published the artcileA practical and total synthesis of pasireotide: Synthesis of cyclic hexapeptide via a three-component condensation, Synthetic Route of 2418-95-3, the publication is Molecules (2019), 24(11), 2185, database is CAplus and MEDLINE.
Pasireotide is a multi-receptor ligand somatostatin analog approved for medical treatment of Cushing’s disease and acromegaly. The liquid-phase total synthesis of pasireotide-a 18-membered cyclic hexapeptide-was achieved by the 3 + 2 + 1 strategy, and the Pro1 -Phe6 peptide bond was selected as the final cyclization position. Two key fragments were simply synthesized using N,O-bis(trimethylsilyl)acetamide/N-hydroxysuccinimide ester (BSA/NHS) as coupling agents, and processes of the two key fragments were simple without any chromatog. purification The current synthesis method is easily scalable and produces the target peptide with an overall yield of 15%.
Molecules published new progress about 2418-95-3. 2418-95-3 belongs to amides-buliding-blocks, auxiliary class Chiral,Carboxylic acid,Amine,Aliphatic hydrocarbon chain,Ester,Amino acide derivatives, name is H-Lys(Boc)-OH, and the molecular formula is C11H22N2O4, Synthetic Route of 2418-95-3.
Referemce:
https://en.wikipedia.org/wiki/Amide,
Amide – an overview | ScienceDirect Topics